XML 20 R3.htm IDEA: XBRL DOCUMENT v3.25.4
Consolidated Statements of Operations - USD ($)
shares in Thousands
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
Dec. 31, 2023
Income Statement [Abstract]      
Net sales $ 1,806,700,000 $ 1,877,500,000 $ 1,893,900,000
Cost of sales 1,446,900,000 1,448,700,000 1,442,900,000
Gross profit 359,800,000 428,800,000 451,000,000.0
Selling, general and administrative expenses 230,700,000 237,800,000 221,900,000
Research and development costs 27,500,000 27,100,000 24,500,000
Loss (recovery) due to misappropriation of assets, net (6,900,000) 59,300,000 0
Goodwill impairment 80,800,000 0 0
Other expense (income), net 200,000 1,900,000 (700,000)
Income from operations 27,500,000 102,700,000 205,300,000
Interest and other financial expense, net 62,300,000 49,400,000 50,900,000
Reclassification of actuarial gains from AOCI 0 0 (8,900,000)
Income (loss) before earnings in affiliated companies and income taxes (34,800,000) 53,300,000 163,300,000
Income tax expense 35,800,000 9,700,000 60,300,000
Earnings in affiliated companies, net of tax 500,000 600,000 500,000
Net income (loss) $ (70,100,000) $ 44,200,000 $ 103,500,000
Weighted-average shares outstanding (in thousands):      
Basic (in shares) 56,324 58,223 58,995
Diluted (in shares) 56,324 58,373 59,980
Earnings (loss) per share      
Basic (in dollars per share) $ (1.24) $ 0.76 $ 1.75
Diluted (in dollars per share) $ (1.24) $ 0.76 $ 1.73